PATENT CLAIM ANALYSIS

Application Number: 16020392
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["514", "645000"]

Abstract:
The invention provides methods of inhibiting the development or progression of a thioesterase deficiency disorder in a mammal by the administration of a compound that functionally mimics the enzymatic activity of all thioesterases in mammals. Such thioesterase deficiency disorders include cancers and adult- or infant-neuronal ceroid lipofuscinoses (NCLs). The invention also provides small molecule mimics of thioesterases useful in the methods of the invention and pharmaceutical compositions containing the therapeutically effective compounds and methods of using the same.

Claim (Index 21):
The pharmaceutical composition of  claim 20 , wherein the pharmaceutically acceptable carrier comprises at least one ingredient selected from the group consisting of lactose, starch, magnesium stearate, stearic acid, and cellulose derivatives.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.59615
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14110393', '15494136', '15100967', '13552975', '15464214']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7342330327012115
- 35 USC 102 Novelty (BERT): 0.6133259839565269
- Combined Prediction Score: 0.7221423278267431
- Mean Citation Score: 281.43311800000004
- Max Citation Score: 642.4936
- Similarity Product: 447.0320391089916

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test